View of Selectivity Barriers in the Therapeutic Target Validation of β-Secretase-1 in the Pathogenesis of Alzheimer's Disease

Return to Article Details Selectivity Barriers in the Therapeutic Target Validation of β-Secretase-1 in the Pathogenesis of Alzheimer's Disease Download Download PDF